Applied and implementation science
Daily report
08 October 2024 (English)
08 October 2024 (Español)
Session reports
OA05 - Early experiences with long-acting PrEP products
OA01 - The big picture: Global trends in HIV prevention
Basic science
Daily report
08 October 2024 (English)
08 October 2024 (Español)
Session reports
SY04 - Back to basics
OA07 - The matrix reloaded: Disrupted immune responses, the way for HIV
Other prevention modalities and cross-cutting issues
Daily report
08 October 2024 (English)
08 October 2024 (Español)
Session reports
OA04 - Latin America in the spotlight: "Caminos" to zero
SY03 - Improving STI prevention and management in conjunction with increasing uptake of HIV prevention products
PrEP and ARV-based prevention
Daily report
08 October 2024 (English)
08 October 2024 (Español)
Session reports
OA02 - Novel antiretrovirals and formulations for prevention
SY02 - Prevention product profiles for future options, including long-acting PrEP formulations and products
Vaccines and bNAbs
Daily report
08 October 2024 (English)
08 October 2024 (Español)
Session reports
PL02 - New tools: New challenges
OA03 - Adaptive immune responses in vaccines
SY01 - Quo vadis: Future design and conduct of vaccine and bNAb clinical trials
OA06 - Monoclonals for prevention
